Latest Advances and Challenges in the Diabetes Community
EASD President Prof. Stefano Del Prato (University of Pisa, Italy) discusses the impact of the COVID-19 pandemic on the diabetes community and the latest emerging therapies in diabetes management.
COVID-19 and type 1 diabetes
We spoke with Prof. Juliana Chan (The Chinese University of Hong Kong, Hong Kong) following her session on COVID-19 and the impact on patients with type 1 diabetes.
Diabetes Complications and Covid-19
The International Diabetes Federation will organise a Virtual Congress on December 6-11, 2021. It will feature the latest research on diabetes complications and sessions dedicated to COVID-19 and diabetes, the centenary of insulin and the IDF Diabetes Atlas 10th Edition. Discover the Congress at https://idf2021.org
COVID-19: Adapting treatment plans and how to keep patients and physicians as safe as possible
European Endocrinology Editor-in-Chief John Doupis provides a Greek perspective on the successes of the government in managing the COVID-19 pandemic. He discusses the adaptations patients and physicians are making to treatment plans, the pivotal role of telemedicine and how caregivers can keep family members and those they live with as safe as possible.
COVID-19: New ways of providing care
COVID-19 is forcing us to change the way we work. Professor Chantal Mathieu from Leuven, Belgium, explains how video and teleconsulting is helping her diabetes centre meet the challenge.
EASD 2020 – Planning a virtual meeting
We were delighted to speak with EASD President Prof. Stefano Del Prato (University of Pisa and University Hospital of Pisa) ahead of this year’s virtual meeting to hear how the meeting has been adapted to a virtual format.
Obesity, diabetes and COVID-19: Challenges and how to keep safe
Dr Osama Hamdy, Harvard Medical School, discusses the greater risk to patients with obesity, diabetes, cardiovascular problems and related health issues, extra precautions to take and the impact COVID-19 is having on clinical practice.
Cortisol and COVID-19—Putting Undue Stress on the “Stress Hormone”
US Endocrinology. 2020;16(2):66–7 DOI: https://doi.org/10.17925/USE.2020.16.2.66
Can Serum Cortisol Be Used To Monitor Patients With COVID-19?
US Endocrinology. 2020;16(2):63–4 DOI: https://doi.org/10.17925/USE.2020.16.2.6
Short-term Hydroxychloroquine in COVID-19 Infection in People With or Without Metabolic Syndrome – Clearing Safety Issues and Good Clinical Practice
European Endocrinology. 2020;16(2):109–12 DOI: https://doi.org/10.17925/EE.2020.16.2.109
Testosterone in COVID-19 – Foe, Friend or Fatal Victim?
European Endocrinology. 2020;16(2):88–91 DOI: https://doi.org/10.17925/EE.2020.16.2.88
Managing Diabetes During the COVID-19 Pandemic
European Endocrinology. 2020;16(2):85–7 DOI: https://doi.org/10.17925/EE.2020.16.2.85
Education activities are developed by touchIME for touchENDOCRINOLOGY.
Our education resources are developed in collaboration with our well established peer-reviewed medical journals, our Editorial Board members and partnerships with major medical societies, with a clear commitment to high-quality independent education.